Dermatology Clinic
UCSF's Pediatric Dermatology Clinic cares for infants, children and adolescents with both common and rare skin disorders. Our team of board certified pediatric dermatologists and experienced clinicians are specially trained and certified to care for children. They have a deep knowledge of treating pediatric skin, hair, and nail disorders and understanding of how different procedures affect your child's health, appearance, and skin healing.
The clinic offers diagnosis and care for atopic dermatitis; psoriasis; disorders of keratinization; inherited skin conditions, such as ectodermal dysplasias; birthmarks, such as the moles some babies are born with; moles with an atypical appearance; and many other skin, hair and nail conditions.
We also offer specialized care for pediatric patients with vascular malformations and vascular tumors, such as hemangiomas, in the UCSF Birthmarks and Vascular Anomalies Center.
Our locations (4)
Our team
-
Regina-Celeste Ahmad
MD, PhD
Pediatric Dermatology -
Sarah Coates
MD
Pediatric Dermatology -
Kelly M. Cordoro
MD
Dermatology, Pediatric Dermatology -
Ilona J. Frieden
MD
Pediatric Dermatology -
Renee M. Howard
MD
Pediatric Dermatology -
Nicole W. Kittler
MD
Pediatric Dermatology -
Erin Mathes
MD
Dermatology, Pediatric Dermatology -
Anubhav Mathur
MD, PhD
Pediatric Dermatology -
Joanna Tu
MD
Pediatric Dermatology -
Maya Loventhal
PA
Dermatology -
Anjali Washington
PA-C
Dermatology
Awards & recognition
-
Ranked among the nation's best in 11 specialties
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Support services
Clinical trials
International CRDS Registry
Composite of malignant syncope, ICD shock, cardiac arrest, and sudden cardiac death
Recruiting
More about this studyRegistry of Patients Diagnosed With Lysosomal Storage Diseases
Prenatal presentation of symptoms (e.g. hydrops) appearing on fetal imaging such as ultrasound and ECHO.
Recruiting
More about this studyA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (C...
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Recruiting
More about this studyISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
Incidence of Adverse Events as assessed by CTCAE (v 5.0)
Recruiting
More about this studyInternational Registry of Patients With Alpha Thalassemia
Number of fetuses diagnosed with alpha thalassemia who survive to birth, compared to number of fetuses diagnosed with alpha thalassemia who have fetal demise or are terminated in utero. This is measured in number of fetuses alive ...
Recruiting
More about this studyStudy of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid...
Tolerability is defined as the proportion of participants receiving at least one dose of combination gemcitabine and paxalisib with a reported dose-limiting toxicity (DLT) during cycle 1 for all participants in Phase I.
Recruiting
More about this studyNaxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Measured by the presence of radiologically assessable disease by cross-sectional computed tomography (CT) or Magnetic resonance imaging (MRI) imaging and/or by metaiodobenzylguanidine (MIBG) or positron emission tomography (PET) s...
Recruiting
More about this studyATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Safety will be measured by those events in the European Safety Surveillance (EUHASS)1: 1. Allergic or other acute events 2. Treatment-emergent side effects of therapy 3. Transfusion transmitted infections 4. Inhibitor ...
Recruiting
More about this studySilmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
To characterize the safety profile of silmitasertib in combination with chemotherapy
Recruiting
More about this studyStress-free visits
Accommodations. Admissions. Procedure prep. Get the info you need for smoother hospital stays.
Prepare for your child's stay
